Ovid Therapeutics
OVID
OVID
82 hedge funds and large institutions have $44.4M invested in Ovid Therapeutics in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 24 increasing their positions, 21 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
82
Holders Change
+7
Holders Change %
+9.33%
% of All Funds
1.09%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
14
Increased
24
Reduced
21
Closed
7
Calls
$4K
Puts
–
Net Calls
+$4K
Net Calls Change
-$30K
Top Buyers
Top Sellers
1 |
PM
Prosight Management
Dallas,
Texas
|
-$860K |
2 |
MAP
Madison Avenue Partners
New York
|
-$368K |
3 |
BlackRock
New York
|
-$360K |
4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$127K |
5 |
BNP Paribas Financial Markets
Paris,
France
|
-$108K |